Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study

barbara.lempert Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic ...

UPDATED: Sanofi joins GSK, MedImmune with 4-in-1 flu vaccine

Eric Palmer The 2013-2014 influenza season will be the first in which vaccines will contain two A and two B strains, and Sanofi-Pasteur says it will be part of the change to the expanded ...

ZIOPHARM Announces Presentation of Updated Results From Ad-RTS-IL-12 Phase I Study

barbara.lempert ZIOPHARM Announces Presentation of Updated Results From Ad-RTS-IL-12 Phase I Study in Advanced Melanoma at the 2013 ASCO Annual Meeting BOSTON, June 1, 2013 (GLOBE ...

UPDATED: Ranbaxy matter sparks backlash years after first being uncovered

Eric Palmer Ranbaxy Laboratories' entanglements with the FDA and federal authorities for foisting adulterated drugs on consumers and then lying to cover it up have been an escalating ...

UPDATED: GlaxoSmithKline bags genetic vaccine developer Okairos for $325 million

John Carroll GlaxoSmithKline ($ GSK) has acquired upstart vaccine developer Okairos for $ 325 million. The deal delivers the Swiss biotech's genetic vaccine development platform, ...

UPDATED: FDA OKs pinpoint prostate cancer radiation drug Xofigo from Bayer, Algeta

John Carroll The approval comes just three months after the FDA granted priority review status for Alpharadin, a radiopharmaceutical from Bayer and Norway's Algeta that will now ...

UPDATED: FDA OKs pinpoint prostate cancer radiation drug Xofigo from Bayer, Algeta

John Carroll The approval comes just three months after the FDA granted priority review status for Alpharadin, a radiopharmaceutical from Bayer and Norway's Algeta that will now ...

UPDATED: GlaxoSmithKline gains blockbuster FDA approval of lung drug Breo

Ryan McBride GlaxoSmithKline and Theravance have won FDA approval for their drug Breo Ellipta for treating chronic obstructive pulmonary disease, the third-biggest killer of Americans, ...

UPDATED: GlaxoSmithKline measures 36-meter leap over placebo in Duchenne walking test

John Carroll GlaxoSmithKline investigator John Kraus reviewed the long-awaited mid-stage results for its Duchenne muscular dystrophy drug drisapersen this afternoon, revealing that ...
Page 6 of 6« First...23456
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS